338 related articles for article (PubMed ID: 35547750)
1. Multi-scale integrative analyses identify THBS2
Yang H; Sun B; Fan L; Ma W; Xu K; Hall SRR; Wang Z; Schmid RA; Peng RW; Marti TM; Gao W; Xu J; Yang W; Yao F
Theranostics; 2022; 12(7):3104-3130. PubMed ID: 35547750
[No Abstract] [Full Text] [Related]
2. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
3. GPX8
Bai Y; Han T; Dong Y; Liang C; Gao L; Liu Y; Zhou J; Guo J; Ge D; Wu J; Hu D
BMC Med Genomics; 2024 Mar; 17(1):77. PubMed ID: 38515109
[TBL] [Abstract][Full Text] [Related]
4. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.
Ren Q; Zhang P; Lin H; Feng Y; Chi H; Zhang X; Xia Z; Cai H; Yu Y
Front Immunol; 2023; 14():1201573. PubMed ID: 37325647
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of tumor microenvironment and prognosis risk prediction in stage I lung adenocarcinoma.
Lu YF; Chang YH; Chen YJ; Hsieh MS; Lin MW; Hsu HH; Han CL; Chen YJ; Yu SL; Chen JS; Chen HY
Lung Cancer; 2024 May; 191():107791. PubMed ID: 38621342
[TBL] [Abstract][Full Text] [Related]
7. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness.
Vasiukov G; Zou Y; Senosain MF; Rahman JSM; Antic S; Young KM; Grogan EL; Kammer MN; Maldonado F; Reinhart-King CA; Massion PP
Sci Rep; 2023 Oct; 13(1):17604. PubMed ID: 37848457
[TBL] [Abstract][Full Text] [Related]
9. Single-cell analyzing of tumor microenvironment and cell adhesion between early and late-stage lung cancer.
Zhu C; Chen Z; Wang S; Cao J; Cheng Y; Zheng M
Mol Immunol; 2024 Jul; 171():1-11. PubMed ID: 38696904
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma.
Lu H; Qian J; Cheng L; Shen Y; Chu T; Zhao C
BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38081768
[TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of lung adenocarcinoma based on cancer-associated fibroblasts genes using scRNA-sequencing.
Zhang H; Wang Y; Wang K; Ding Y; Li X; Zhao S; Jia X; Sun D
Aging (Albany NY); 2023 Jul; 15(14):6774-6797. PubMed ID: 37437244
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma.
Liu T; Han C; Fang P; Ma Z; Wang X; Chen H; Wang S; Meng F; Wang C; Zhang E; Dong G; Zhu H; Yin W; Wang J; Zuo X; Qiu M; Wang J; Qian X; Shen H; Xu L; Hu Z; Yin R
J Hematol Oncol; 2022 Oct; 15(1):141. PubMed ID: 36209111
[TBL] [Abstract][Full Text] [Related]
13. Integrating bulk RNA-seq and scRNA-seq analyses revealed the function and clinical value of thrombospondins in colon cancer.
Li J; Tang Y; Long F; Tian L; Tang A; Ding L; Chen J; Liu M
Comput Struct Biotechnol J; 2024 Dec; 23():2251-2266. PubMed ID: 38827236
[TBL] [Abstract][Full Text] [Related]
14. Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
Melocchi V; Dama E; Mazzarelli F; Cuttano R; Colangelo T; Di Candia L; Lugli E; Veronesi G; Pelosi G; Ferretti GM; Taurchini M; Graziano P; Bianchi F
Oncogene; 2021 Aug; 40(31):4980-4991. PubMed ID: 34172935
[TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
17. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
[TBL] [Abstract][Full Text] [Related]
18. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
Front Immunol; 2021; 12():723172. PubMed ID: 34539658
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis.
Wang Z; Yang L; Wang W; Zhou H; Chen J; Ma Z; Wang X; Zhang Q; Liu H; Zhou C; Guo Z; Zhang X
Cell Commun Signal; 2023 Nov; 21(1):325. PubMed ID: 37957625
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]